Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

Evaluating a new hydrogel to prevent adhesions after ankle ligament surgery

Official title: A Prospective, Single-center, Randomized, Evaluator/subject-blinded, Controlled Clinical Study: to Evaluate the Effectiveness of the Use of a Novel Crosslinking Hyaluronan Hydrogel on the Prevention of the Adhesion Occurrence After Anterior Talofibular Ligament Repair Surgery

Run by Talent Cro Inc. · NCT06826898 · Data updated 2026-11-12

This study is testing a new gel to see if it can help people who have had ankle ligament surgery avoid painful scar tissue and improve their ankle movement.

More Anterior Cruciate Ligament Injury trials

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment50 (estimated)
SponsorTalent Cro Inc.
Academic / other
Locations1 site (Changhua)
StatusRecruiting
StartedMarch 1, 2025
Main results expectedApril 30, 2026
Study endsJune 30, 2026
Registry record updatedFebruary 14, 2025
Trial IDNCT06826898 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 60 with confirmed anterior talofibular ligament injuries and a history of recurrent ankle sprains.

Probably not a fit

Patients with severe ankle osteoarthritis, prior ankle surgeries, or uncontrolled chronic diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to assess the effectiveness of a novel crosslinking hyaluronan hydrogel in preventing adhesions following anterior talofibular ligament repair surgery. Participants will be randomly assigned to receive either the hydrogel or a sham treatment, with the expectation that those receiving the hydrogel will experience improved range of motion in their ankle. The study focuses on patients with confirmed anterior talofibular ligament injuries who have not responded to conservative treatments. The trial will monitor outcomes related to adhesion formation and functional recovery post-surgery.

Why it matters

Potential benefit: If successful, this treatment could significantly improve recovery outcomes for patients undergoing ankle ligament repair by reducing adhesion formation.

How similar studies have gone: While this approach is innovative, similar studies using adhesion barriers have shown promise in other surgical contexts.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1.1 Voluntarily participate and sign an informed consent form; 1.2 Age 18 to 60 years of male or female; 1.3 Patients experiencing lateral ankle pain discomfort, confirmed by MRI to have anterior talofibular ligament (ATFL) injury; 1.4 History of recurrent ankle inversion sprains three times or more, with no improvement after six months of conservative treatment, and scheduled for ATFL repair surgery; 1.5 Willing to comply with all follow-up requirements of the trial protocol.

Exclusion Criteria:

2.1 Severe ankle osteoarthritis; 2.2 Patients with a history of ankle fracture or surgery; 2.3 Undergoing foot- or ankle-related treatments that may affect the trial results; 2.4 Presence of skin infection, skin defects, or need for skin grafting at the surgical site; 2.5 Uncontrolled chronic diseases, such as diabetes mellitus; 2.6 Presence of autoimmune diseases (such as Autoimmune Collagenopathy, rheumatoid arthritis), malignancies, coagulation disorders, heart diseases, psychiatric illnesses, or other conditions that may pose higher risks to patients in the trial; 2.7 Use of corticosteroids within the past 6 months, systemic corticosteroids within the past month, immunosuppressive drugs within the past 3 months, or daily use of non-steroidal anti-inflammatory drugs (NSAIDs) within the past week, or occasional use within 8 hours (patients using nasal/inhaled corticosteroids may be considered for inclusion) ; 2.8 Clinically significant coagulation abnormalities or undergoing anticoagulant therapy within 10 days before surgery or currently taking anticoagulant drugs; 2.9 Known allergy to sodium hyaluronate or any components of medical devices;allergy to Gram-positive bacterial protein or streptococcal protein;or other severe allergic history deemed unsuitable for participation by the investigators; 2.10 Pregnant, lactating women, or women planning to become pregnant during the trial period; 2.11 Other conditions deemed unsuitable for participation by the investigators.

Where it's running

  • Show Chwan Memorial Hospital
    Changhua, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.